MedTrace Logo

Intravenous Lidocaine Versus Morphine for Severe Pain in the ED

NCT02912195 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-04-06

Study results available
· View outcomes & findings →

Summary

Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider chosen dose of IV morphine for the treatment of severe pain in the emergency department.

Study design: Open-label, randomized controlled pilot study.

Conditions

Interventions

DRUG

Intravenous lidocaine

Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes

DRUG

Intravenous morphine

Emergency department provider chooses appropriate dose of intravenous morphine

Sponsors & Collaborators

  • Alameda Health System

    lead OTHER

Principal Investigators

  • Andrew Herring, MD · Alameda Health System, Highland Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02912195 on ClinicalTrials.gov